Skip to main content
Erschienen in: Medical Oncology 1/2013

01.03.2013 | Original Paper

Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases

verfasst von: Xiaoyu Yang, Aijun Li, Mengchao Wu

Erschienen in: Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to review the main clinical, imaging and pathological features of hepatic angiomyolipoma (HAML). We retrospectively analyzed the imaging, pathological and clinical features of 178 patients who underwent surgical resection for HAML. Forty-three males and 135 females with a median age of 43.5 years (range: 17–76 years) were enrolled in the study. Routine blood tests, including those for α-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen determinant, were normal. Liver function was classified as Child-Pugh A for all patients. Twenty-one patients were positive for hepatitis B surface antigen (HBsAg), while two had liver cirrhosis. Seventy-five lesions were located in the right hepatic lobe, 42 in the left hepatic lobe, 12 in the hepatic caudal lobe, and 49 in both left and right lobe. All patients underwent examination by ultrasound sonography (US), and additional examinations by computed tomography (CT) and magnetic resonance (MR) were carried out for 115 and 81 patients, respectively. Various diseases including HAML, liver cancer, liver hemangioma, hepatic lipoma, hepatic hamartoma, focal nodular hyperplasia and liver adenoma were diagnosed before operation. CT and MRI are more conclusive than US (US vs CT: χ2 = 17.72, P = 0.00; US vs MRI: χ2 = 12.14, P = 0.00), but for the sensitivity of these three imaging modalities, MRI performs the best (US vs MRI: χ2 = 5.938, P = 0.015; CT vs MRI: χ2 = 2.544, P = 0.111). All the patients underwent liver resection (96 right hepatic lobectomy, 41 left hepatic lobectomy and nine caudal lobe hepatic lobectomy). Several sampled tissues were positive for HBsAg (21/168, 12.5 %), β-catenin (4/41, 9.8 %), CD-34 (119/165, 72.1 %), HMB-45 (162/169, 92.9 %), SMA (145/158, 91.8 %) and vimentin (20/27, 74.1 %). The diagnosis of HAML remains difficult and mainly relies on pathological findings. For the imaging modalities, we recommend MRI examination because of its better definition and sensitivity. Although HMB-45 is considered the main histopathological biomarker for HAML, SMA may be also helpful in the diagnostic process (HMB-45 vs SMA: χ2 = 2.37, P = 0.123). When the diagnosis of HAML is suspicious or hypothesized, surgical resection remains the recommended strategy due to the difficulty in diagnosis preoperatively and the potentially invasive growth of the lesion.
Literatur
1.
Zurück zum Zitat Ishak KG. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. p. 247–307. Ishak KG. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. p. 247–307.
2.
Zurück zum Zitat Ding G-H, Liu Y, Wu M-C, et al. Diagnosis and treatment of hepatic angiomyolipoma. J Surg Oncol. 2011;103:807–12.PubMedCrossRef Ding G-H, Liu Y, Wu M-C, et al. Diagnosis and treatment of hepatic angiomyolipoma. J Surg Oncol. 2011;103:807–12.PubMedCrossRef
3.
Zurück zum Zitat Hirohashi S, Blum HE, Ishak KG. Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics. Tumours of the digestive system. World Health Organisation classification of tumours. Lyon: IARC Press; 2000. p. 157–202. Hirohashi S, Blum HE, Ishak KG. Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics. Tumours of the digestive system. World Health Organisation classification of tumours. Lyon: IARC Press; 2000. p. 157–202.
4.
Zurück zum Zitat Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radio-graphics. 2005;25(2):321–31. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radio-graphics. 2005;25(2):321–31.
5.
Zurück zum Zitat Yeh CN, Lee KF, Chen MF. Immunohistochemical study of hepatic angiomyolipoma. Hepatogastroenterology. 2005;56:1151–3. Yeh CN, Lee KF, Chen MF. Immunohistochemical study of hepatic angiomyolipoma. Hepatogastroenterology. 2005;56:1151–3.
6.
Zurück zum Zitat Tsui WMS, Colombari R, Portmann B, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.PubMedCrossRef Tsui WMS, Colombari R, Portmann B, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.PubMedCrossRef
7.
Zurück zum Zitat Wang SN, Tsai KB, Lee KT. Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review. J Clin Pathol. 2006;59:1196–9.PubMedCrossRef Wang SN, Tsai KB, Lee KT. Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review. J Clin Pathol. 2006;59:1196–9.PubMedCrossRef
8.
Zurück zum Zitat Dalle L, Sciot R, De Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;35:443–50.CrossRef Dalle L, Sciot R, De Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;35:443–50.CrossRef
9.
Zurück zum Zitat Yang CY, Ho MC, Jeng YM, Hu RH, Wu MY, Lee PH. Management of hepatic angiomyolipoma. J Gastrointest Surg. 2007;11:452–7.PubMedCrossRef Yang CY, Ho MC, Jeng YM, Hu RH, Wu MY, Lee PH. Management of hepatic angiomyolipoma. J Gastrointest Surg. 2007;11:452–7.PubMedCrossRef
10.
Zurück zum Zitat Petrolla AA, Xin W. Hepatic angiomyolipoma. Arch Pathol Lab. 2008;132:1679–82. Petrolla AA, Xin W. Hepatic angiomyolipoma. Arch Pathol Lab. 2008;132:1679–82.
11.
Zurück zum Zitat Carmody E, Yeung E, McLoughlin M. Angiomyolipomas of the liver in tuberous sclerosis. Abdom Imaging. 1994;19:537–9.PubMedCrossRef Carmody E, Yeung E, McLoughlin M. Angiomyolipomas of the liver in tuberous sclerosis. Abdom Imaging. 1994;19:537–9.PubMedCrossRef
12.
Zurück zum Zitat Ren N, Qin LX, Tang ZY, et al. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9:1856–8.PubMed Ren N, Qin LX, Tang ZY, et al. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9:1856–8.PubMed
13.
Zurück zum Zitat Xu AM, Zhang SH, Zheng JM, et al. Pathological and molecular analysis of sporadic hepatic angiomyolipoma. Hum Pathol. 2006;37:735–41.PubMedCrossRef Xu AM, Zhang SH, Zheng JM, et al. Pathological and molecular analysis of sporadic hepatic angiomyolipoma. Hum Pathol. 2006;37:735–41.PubMedCrossRef
14.
Zurück zum Zitat Li T, Wang L, Yu H–H, et al. Hepatic angiomyolipoma: a retrospective study of 25 cases. Surg Today. 2008;38:529–35.PubMedCrossRef Li T, Wang L, Yu H–H, et al. Hepatic angiomyolipoma: a retrospective study of 25 cases. Surg Today. 2008;38:529–35.PubMedCrossRef
Metadaten
Titel
Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases
verfasst von
Xiaoyu Yang
Aijun Li
Mengchao Wu
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0416-4

Weitere Artikel der Ausgabe 1/2013

Medical Oncology 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.